$CRWD Cashflow Statement | Understand Stock

$CRWD

$267.99 +$6.16 (2.35%) Live

$CRWD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jan 31, 2026	FY2025 12 months to Jan 31, 2025	FY2024 12 months to Jan 31, 2024	FY2023 12 months to Jan 31, 2023	FY2022 12 months to Jan 31, 2022
Operating activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
Amortization of intangible assets
Amortization of deferred contract acquisition costs
Non-cash operating lease cost
Change in fair value of redeemable convertible preferred stock warrant liability
Stock-based compensation expense
Deferred income taxes
Gain on sale of debt securities, net
Realized gains on strategic investments
Accretion of short-term investments purchased at a discount
Non-cash interest expense
Other non-cash charges
Change in fair value of strategic investments
Changes in operating assets and liabilities, net of impact of acquisitions
Accounts receivable, net
Deferred contract acquisition costs
Prepaid expenses and other assets
Accounts payable
Accrued expenses and other liabilities
Accrued payroll and benefits
Operating lease liabilities
Deferred revenue

Net cash provided by operating activities
Investing activities
Purchases of property and equipment
Capitalized internal-use software and website development costs
Purchases of strategic investments
Proceeds from sales of strategic investments
Business acquisitions, net of cash and restricted cash acquired
Purchases of intangible assets
Purchases of marketable securities
Proceeds from sales of marketable securities
Proceeds from sales of investments
Purchases of short-term investments
Proceeds from maturities and sales of short-term investments
Purchases of deferred compensation investments
Maturities of marketable securities
Proceeds from the sale of deferred compensation investments
Net cash used in investing activities

Financing activities
Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts
Payments of debt issuance costs related to revolving line of credit
Payments of debt issuance costs related to Senior Notes
Proceeds from issuance of Senior Notes, net of debt financing costs
Payments of deferred offering costs
Repayment of loan payable
Proceeds from issuance of common stock upon exercise of stock options
Proceeds from the issuance of common stock upon exercise of early exercisable stock options
Proceeds from issuance of common stock under the employee stock purchase plan
Settlement related to stockholder short-swing trade profit
Distributions to non-controlling interest holders
Capital contributions from non-controlling interest holders
Net cash provided by financing activities

Effect of foreign exchange rates on cash, cash equivalents, and restricted cash
Net increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash
Supplemental disclosure of cash flow information:
Interest paid
Income taxes paid, net of refunds received
Supplemental disclosure of non-cash investing and financing activities:
Conversion of redeemable convertible preferred stock to common stock
Conversion of redeemable convertible preferred stock warrant liabilities reclassified to additional paid-in capital
Net decrease in deferred offering costs, accrued but not paid
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses
Vesting of early exercised stock options
Equity consideration for acquisitions
Debt financing costs, accrued but not paid
Operating lease liabilities arising from obtaining operating right of-use assets
Operating lease liabilities arising from obtaining operating right-of-use assets
Proceeds from sales of strategic investments not yet received
Stock-based compensation included in capitalized software development costs and fixed assets
Noncash consideration for the purchase of strategic investments
Noncash consideration received from sales of strategic investments
Fair value of common stock to be issued for consideration transferred
Restricted cash held in escrow for purchase consideration for business combinations

Cash and cash equivalents
Restricted cash included in prepaid expenses and other current assets
Restricted cash included in other long-term assets

Comments